Click here to close now.

Welcome!

News Feed Item

Quarterly Performance Reviews, Dividends, and Legal Updates - Research Reports on T. Rowe, BB&T, Teva, HCA Holdings and Boston Scientific

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, August 13, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding T. Rowe Price Group, Inc. (NASDAQ: TROW), BB&T Corporation (NYSE: BBT), Teva Pharmaceutical Industries Limited (NYSE: TEVA), HCA Holdings, Inc. (NYSE: HCA) and Boston Scientific Corporation (NYSE: BSX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5696-100free.

--
T. Rowe Price Group, Inc. Research Reports
On July 24, 2014, T. Rowe Price Group, Inc. (T. Rowe) announced its Q2 2014 financial results. The Company's net revenue during the quarter increased 15.2% YoY to $984.3 million. Investment advisory revenues of the Company rose 15.6% YoY to $855.3 million, as average assets under management (AUM) increased $92.1 billion. During the quarter, market appreciation and income of $27.2 billion, offset slightly by net cash outflows from investors of $200 million, lifted Company's AUM to a record $738.4 billion at June 30, 2014. Net income attributable to common shareholders increased to $302.4 million or $1.13 per diluted share, compared with $245.8 million, or $0.92 per diluted share, in Q2 2013. On average, analysts polled by Bloomberg expected the Company's net income per share at $1.12. The full research reports on T. Rowe are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/TROW/report.pdf

--
BB&T Corporation Research Reports
On July 22, 2014, BB&T Corporation (BB&T) announced that its Board of Directors has declared the following quarterly dividends: $0.24 per share on BB&T's common stock; $365.625 per share on BB&T's Series D Non-Cumulative Perpetual Preferred Stock; $351.5625 per share on BB&T's Series E Non-Cumulative Perpetual Preferred Stock; $325.000 per share on BB&T's Series F Non-Cumulative Perpetual Preferred Stock; and $325.000 per share on BB&T's Series G Non-Cumulative Perpetual Preferred Stock. The Company said that these quarterly dividends are payable on September 2, 2014, to shareholders of record at the close of business on August 8, 2014. The full research reports on BB&T are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/BBT/report.pdf

--
Teva Pharmaceutical Industries Limited Research Reports
On August 7, 2014, Teva Pharmaceutical Industries Limited (Teva) confirmed that it has received the first paragraph IV notice for its three-times-a-week COPAXONE® 40 mg/mL product from Dr. Reddy's Laboratories, Inc. (Dr. Reddy's). The Company stated that it will continue to defend its COPAXONE® intellectual property rights against infringement, wherever challenged. Teva plans to file a lawsuit for patent infringement against Dr. Reddy's within 45 days, which will trigger a 30 month stay of FDA approval of Dr. Reddy's ANDA. Teva informed that COPAXONE® 40 mg/mL is protected by two Orange Book patents expiring in 2030. The full research reports on Teva are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/TEVA/report.pdf

--
HCA Holdings, Inc. Research Reports
On August 8, 2014, the stock of HCA Holdings, Inc. (HCA) declined 0.13% to end the trading session at $67.13. During the session, the stock opened at $67.21, and fluctuated in the range of $65.85 - $67.72, with a total of 3.35 million shares changing hands. Over the last one month, the Company's stock has increased by 22.17%, outperforming the Dow Jones Industrial Average, which declined 2.54% during the same period. The full research reports on HCA Holdings are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/HCA/report.pdf

--
Boston Scientific Corporation Research Reports
On July 30, 2014, Bloomberg reported that Boston Scientific Corporation (Boston Scientific) has won the first case to go trial over its vaginal-mesh devices. According to the report, a jury in state court in Massachusetts rejected Diane Albright's claims that the mesh's faulty design caused her injuries and found that the Company's officials had adequately warned Albright of device's risks. Bloomberg stated that the verdict is first in more than 12,000 lawsuits in which women have charged the Company of making vaginal-mesh devices that ends up causing organ damage and pain. The full research reports on Boston Scientific are available to download free of charge at:

http://www.analystsreview.com/Aug-13-2014/BSX/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The 5th International DevOps Summit, co-located with 17th International Cloud Expo – being held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the ...
DevOps Summit, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development...
IT data is typically silo'd by the various tools in place. Unifying all the log, metric and event data in one analytics platform stops finger pointing and provides the end-to-end correlation. Logs, metrics and custom event data can be joined to tell the holistic story of your software and operations. For example, users can correlate code deploys to system performance to application error codes. In his session at DevOps Summit, Michael Demmer, VP of Engineering at Jut, will discuss how this can...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
The 17th International Cloud Expo has announced that its Call for Papers is open. 17th International Cloud Expo, to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, APM, APIs, Microservices, Security, Big Data, Internet of Things, DevOps and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding bu...
"AgilData is the next generation of dbShards. It just adds a whole bunch more functionality to improve the developer experience," noted Dan Lynn, CEO of AgilData, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
The basic integration architecture, as defined by ESBs, hasn’t changed for more than a decade. Most cloud integration providers still rely on an ESB architecture and their proprietary connectors. As a result, enterprise integration projects suffer from constraints of availability and reliability of these connectors that are not re-usable across other integration vendors. However, the rapid adoption of APIs and almost ubiquitous availability of APIs amongst most SaaS and Cloud applications are ra...
SYS-CON Events announced today that Secure Infrastructure & Services will exhibit at SYS-CON's 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Secure Infrastructure & Services (SIAS) is a managed services provider of cloud computing solutions for the IBM Power Systems market. The company helps mid-market firms built on IBM hardware platforms to deploy new levels of reliable and cost-effective computing and hig...
The most often asked question post-DevOps introduction is: “How do I get started?” There’s plenty of information on why DevOps is valid and important, but many managers still struggle with simple basics for how to initiate a DevOps program in their business. They struggle with issues related to current organizational inertia, the lack of experience on Continuous Integration/Delivery, understanding where DevOps will affect revenue and budget, etc. In their session at DevOps Summit, JP Morgenthal...
"We help to transform an organization and their operations and make them more efficient, more agile, and more nimble to move into the cloud or to move between cloud providers and create an agnostic tool set," noted Jeremy Steinert, DevOps Services Practice Lead at WSM International, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
The time is ripe for high speed resilient software defined storage solutions with unlimited scalability. ISS has been working with the leading open source projects and developed a commercial high performance solution that is able to grow forever without performance limitations. In his session at Cloud Expo, Alex Gorbachev, President of Intelligent Systems Services Inc., shared foundation principles of Ceph architecture, as well as the design to deliver this storage to traditional SAN storage co...
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.
17th Cloud Expo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises ar...
Overgrown applications have given way to modular applications, driven by the need to break larger problems into smaller problems. Similarly large monolithic development processes have been forced to be broken into smaller agile development cycles. Looking at trends in software development, microservices architectures meet the same demands. Additional benefits of microservices architectures are compartmentalization and a limited impact of service failure versus a complete software malfunction. ...
Discussions about cloud computing are evolving into discussions about enterprise IT in general. As enterprises increasingly migrate toward their own unique clouds, new issues such as the use of containers and microservices emerge to keep things interesting. In this Power Panel at 16th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the state of cloud computing today, and what enterprise IT professionals need to know about how the latest topics and trends affect t...